Physician profile
Christopher Patrick Burton
NPI 1508353525
$9,955.72
in general payments reported to CMS, 2019-2025
11 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2022: $6,652 · 2023: $1,388 · 2024: $451 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,036 · Travel and Lodging: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,036.26 |
| Travel and Lodging | $128.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,975.83 | 2022-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $425.51 | 2023-2024 | Senza |
| Saluda Medical Americas, INC. | $338.78 | 2023 | Evoke Scs |
| Spr Therapeutics, INC | $207.67 | 2023-2025 | Sprint Pns System |
| Stratus Medical, LLC | $204.35 | 2023 | Nimbus |
| Globus Medical, INC. | $189.16 | 2025 | Senza |
| Boston Scientific Corporation | $150.00 | 2024 | |
| Merz North America, INC. | $138.68 | 2019 | |
| Nalu Medical, INC. | $136.18 | 2023 | Nalu Neurostimulation System |
| Abbott Laboratories | $103.66 | 2025 | Eterna |
| Relievant Medsystems, INC. | $85.90 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.